Regulatory Factsheet
Orphan Drug Designation (EU & UK)
In order to be eligible for Orphan Drug Designation (ODD) with the EMA, a product must fulfill certain criteria for designation as an orphan medicine so that it can benefit from incentives such as protection from competition once on the market. Download our 2 page Orphan Drug Designation (EU & UK) factsheet for more information.